ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Tech And Strategies For Reaching Underserved Patient Populations

  By leveraging flexible solutions, learn how sponsors can proactively address regulatory mandates while advancing the development of safer and more effective therapies for a broader spectrum of patients.

• Patient Recruitment From A Site Perspective

  When used strategically and in conjunction with traditional enrollment methods, see how technology can significantly enhance patient recruitment efforts.

• How To Make eConsent Accessible Across Diverse Populations

  Accessible eConsent removes language, literacy, disability, and tech barriers, improving comprehension, equity, compliance, participant trust, inclusive enrollment, and data quality.

• One Day, Clinical Trials Will Represent The Real World

  What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.

• The Strategic Case For RTSM in Phase 1 Trials

  Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.

• Supporting Early Phase Oncology Research With The Right Data Management System

  Better understand how the evolving landscape drives innovation, why your data capture strategy needs the right technology foundation, and what to look for in a CDMS/EDC system for early-phase oncology.

• eCOA 101: What Is Electronic Clinical Outcome Assessment?

  Electronic Clinical Outcome Assessment (eCOA) has transformed data collection in clinical trials by prioritizing patient engagement and improving data accuracy.

• Frequently Asked Questions About IRMS MAX

  Improve your information access and capabilities with the definitive gold standard of medical information systems.

• Tackling Feasibility In Rare Disease Clinical Trials

  Rare disease clinical trials face distinct challenges, but the right data strategy can offer a transformative approach to addressing complexities and enhancing enrollment.

• Accelerating Your New Therapies Path To Market With Automation

  Automation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.